Kronos Bio Announces Selection of Autoimmune Development Candidate for Sjögren’s Disease

– KB-7898, a p300 KAT inhibitor, is the Company's first development candidate for autoimmune diseases and originates from its proprietary discovery engine that decodes complex transcription factor regulatory networks –

Read more at globenewswire.com